Status:
COMPLETED
Brainsway DTMS for Treatment of MDD Using iTBS
Lead Sponsor:
Brainsway
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The safety and effectiveness of the BrainsWay deep transcranial magnetic stimulation (DTMS) device for the intended use of Major Depressive Disorder (MDD) using the intermittent theta-burst (iTBS) sti...
Detailed Description
The purpose of the study is to evaluate the safety and efficacy of Brainsway Deep TMS for the treatment of Major Depressive Disorder using the iTBS stimulation protocol, by comparing it to clinical da...
Eligibility Criteria
Inclusion
- Outpatients
- Diagnosis of Major Depression Disorder
Exclusion
- Other significant Axis I psychiatric disorder with greater impairment than MDD
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
177 Patients enrolled
Trial Details
Trial ID
NCT04679753
Start Date
January 1 2019
End Date
July 1 2020
Last Update
December 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SynapseTMS
Yorkton, Saskatchewan, Canada, S3N 4C6